semaglutide doping Weight Loss Drugs: What athletes need to know about GLP-1s February 20, 2024: FDA warns

Novo Nordisk's GLP-1 agonist Ozempic (semaglutide) has been available in China for diabetes since 2021, and the Wegovy formulation for obesity got the green light from the NMPA last month

Puukila S, Lemon JA, Lees SJ, Tai TC, Boreham DR, Khaper N

Kim MS, Baek MJ, Lee MH, Park JW, Lee SY, Sderhll K, Lee BL (2002) A new easter-type serine protease cleaves a masquerade-like protein during prophenoloxidase activation in Holotrichia diomphalia larvae

( Ref: 6

This cascade restores PINK1/Parkin-dependent mitophagy and concurrently activates the NRF2 pathway, enhancing antioxidant responses, like NQO-1and HO-1, and consequently reducing oxidative stress in ectopic lesions